Vestal Point Capital »

Dianthus Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 600k 25.88

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Dianthus Therapeutics

Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
BlackRock
Vanguard Group
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Henderson Group
Vestal Point Capital
Geode Capital Management
State Street Corporation
Braidwell

View all funds holding Dianthus Therapeutics